Tariffs Threaten Life Saving Generics, Not Big Pharma's Bottom Line Richard Saynor, CEO of Sandoz, recently warned that "patients pay the tariff.
" This stark reminder comes as President Trump considers imposing tariffs on generic drugs.
The implications are far reaching and disturbing: these tariffs would harm patients who rely on life saving medications and undermine the US healthcare system.